Cited by 95Mycobacterium research and diagnosisTuberculosis Research and EpidemiologyLeprosy Research and Treatment

Mycolactone-Mediated Inhibition of Tumor Necrosis Factor Production by Macrophages Infected with Mycobacterium ulcerans Has Implications for the Control of Infection

Open access
Torrado, Egídio, Adusumilli, Sarojini, Fraga, Alexandra G., Small, Pamela L. C., Castro, António G., Pedrosa, Jorge·2007·Infection and Immunity

Abstract

The pathogenicity of Mycobacterium ulcerans, the agent of Buruli ulcer, depends on the cytotoxic exotoxin mycolactone. Little is known about the immune response to this pathogen. Following the demonstration of an intracellular growth phase in the life cycle of M. ulcerans, we investigated the production of tumor necrosis factor (TNF) induced by intramacrophage bacilli of diverse toxigenesis/virulence, as well as the biological relevance of TNF during M. ulcerans experimental infections. Our data show that murine bone marrow-derived macrophages infected with mycolactone-negative strains of M. ulcerans(nonvirulent) produce high amounts of TNF, while macrophages infected with mycolactone-positive strains of intermediate or high virulence produce intermediate or low amounts of TNF, respectively. These results are in accordance with the finding that TNF receptor P55-deficient (TNF-P55 KO) mice are not more susceptible than wild-type mice to infection by the highly virulent strains but are more susceptible to nonvirulent and intermediately virulent strains, demonstrating that TNF is required to control the proliferation of these strains in animals experimentally infected by M. ulcerans. We also show that mycolactone produced by intramacrophage M. ulcerans bacilli inhibits, in a dose-dependent manner, but does not abrogate, the production of macrophage inflammatory protein 2, which is consistent with the persistent inflammatory responses observed in experimentally infected mice.

Integrity signals

Registry

Crossref · 10.1128/iai.00290-07

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Mycolactone contributes to immunosuppression by hampering the production of several cytokines and chemokines from macrophages.

    “In addition, mycolactone contributes to immunosuppression by hampering the production of several cytokines and chemokines from macrophages (Figure 2A) (99–101); mycolactone is effective at dampening the production of LPS-induced mediators.”
  • Mycolactone is effective at dampening the production of LPS-induced mediators.

    “In addition, mycolactone contributes to immunosuppression by hampering the production of several cytokines and chemokines from macrophages (Figure 2A) (99–101); mycolactone is effective at dampening the production of LPS-induced mediators.”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Torrado, E., Adusumilli, S., Fraga, A. G., Small, P. L. C., Castro, A. G., & Pedrosa, J.
Affiliations
  • Life and Health Sciences Research Institute (ICVS), School of Health Sciences, University of Minho, Braga, Portugal
  • University of Tennessee at Knoxville (US)
  • University of Minho (PT)
Venue
Infection and Immunity
Published
2007-08
Volume
75
Issue
8
Pages
3979-3988
ISSN
  • 0019-9567 (ISSN-L)
  • 1098-5522
OpenAlex
W2136236947
Cited by
95
References
2
Citations by year
2024: 2 · 2023: 2 · 2022: 2 · 2021: 1 · 2020: 3 · 2019: 7 · 2018: 2 · 2017: 6 · 2016: 9 · 2015: 6 · 2014: 8 · 2013: 7 · 2012: 4
FWCI
8.06
Type
journal article
Language
en
Open access
Locations
  • Infection and Immunity (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) (submittedVersion, other-oa)
Funders
Fundação para a Ciência e a Tecnologia (SFRH/BD/15911/2005)
Topics
  • Health Sciences › Medicine › Epidemiology › Mycobacterium research and diagnosis
  • Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
  • Health Sciences › Medicine › Infectious Diseases › Leprosy Research and Treatment
Keywords
Mycobacterium ulcerans, mycolactone, Buruli ulcer, TNF-α, macrophages, virulence, TNF receptor p55, CXCL2, host immune response, experimental infection, bacterial exotoxins
MeSH terms
Animals, Bacterial Toxins, Cells, Cultured, Disease Models, Animal, Female, Foot, Macrophages, Mice, Inbred BALB C, Mice, Inbred C57BL, Mycobacterium Infections, Nontuberculous, Tumor Necrosis Factor-alpha, Virulence, Monokines, Mice, Knockout, Macrolides, Mycobacterium ulcerans, Receptors, Tumor Necrosis Factor, Type I, Mice, Tumor Necrosis Factor Decoy Receptors, Chemokine CXCL2

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review